Searched for
CIPLA STOCK ANALYSIS
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...- For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Two Trades for Today: A pharma major for an 8.1% upmove, a mid-cap specialty chemical stock for a rise of about 6%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Most hated stocks: FIIs dumping these 146 companies without a break for 4 straight quarters. Do you own any?Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...
- Cipla shares slide 5% after temporary halt in key drug manufacturingCipla shares fell sharply on Friday after a halt in Lanreotide Injection production due to USFDA observations at its Greek partner. Supply ...
- 2 top stock recommendations from Rajesh Palviya for next weekEntering the August expiry week, Nifty faces a supply zone at 25,000–25,200, with potential consolidation above 24,800. Bank Nifty appears ...
- 2 top stock recommendations from Sneha SethSneha Seth from Angel One suggests booking profits for intraday positions in index options. She notes potential resistance at 23,000-23,100...
- F&O Radar | Deploy Bull Call Spread in Cipla for gains from bullish momentumCipla shares broke out from a falling trendline, signaling bullish momentum. A close above Rs 1,500 could drive prices to Rs 1,540–1,580. R...
- Stocks to buy today: Cipla, ONGC among top 9 trading ideas for 19 February 2025The Indian market is expected to consolidate on Wednesday, influenced by muted global cues. The Nifty futures closed slightly negative, wit...
- F&O Stock Strategy: How to trade Canara Bank, Cipla and CromptonWhile the overall market may remain in a consolidation mode for some time, there is potential for noteworthy stock-specific movements in th...
- BPCL, Coal India among 10 Nifty stocks with golden crossover patternOn September 20, Wednesday, Trendlyne uncovered an intriguing pattern in the stock market - the Golden Crossover. In this article, we delve...
- Stock Radar: Pharma stocks in focus! Cipla could retest record highs in short termShort-term traders can buy the stock for a possible short-covering move which could take the stock towards 1275 levels, suggest experts. Th...
- BPCL, Cipla among 10 Nifty stocks with golden crossover patternOn September 22, Friday, Trendlyne reported that more than 40 Nifty stocks experienced a Golden Crossover, a powerful indicator for traders...
- M&M, Godrej Properties and 5 other stocks break above 200-day SMAIn technical analysis, when a stock's price surpasses its 200-day Simple Moving Average (SMA), it is seen as a bullish signal. Several stoc...
- In next 2-3 months, India more likely to underperform: Sandip Sabharwal“I would still be cautious through October because the typical parameters which define a sort of bottom formation in the US markets also do...
- Cipla movement under Sebi lensTHE SECURITIES and Exchange Board of India has initiated a probe into the price movement of pharma major Cipla prior to its inclusion in th...
Load More
